Pharmaceuticals Companies By Roe

Return On Equity
ROEEfficiencyMarket RiskExp Return
1NVO Novo Nordisk AS
0.89
(0.10)
 2.43 
(0.25)
2LLY Eli Lilly and
0.59
(0.02)
 2.35 
(0.04)
3SIGA SIGA Technologies
0.58
(0.05)
 6.37 
(0.31)
4ZTS Zoetis Inc
0.49
 0.09 
 1.33 
 0.12 
5COLL Collegium Pharmaceutical
0.48
 0.09 
 2.74 
 0.26 
6HROWL Harrow Health 8625
0.45
 0.05 
 0.42 
 0.02 
7MRK Merck Company
0.33
(0.14)
 1.64 
(0.22)
8GSK GlaxoSmithKline PLC ADR
0.33
 0.03 
 1.60 
 0.05 
9AMPH Amphastar P
0.26
 0.12 
 2.57 
 0.31 
10CORT Corcept Therapeutics Incorporated
0.25
 0.23 
 2.39 
 0.55 
11INVA Innoviva
0.24
 0.19 
 1.25 
 0.24 
12HRMY Harmony Biosciences Holdings
0.22
 0.03 
 2.63 
 0.07 
13JNJ Johnson Johnson
0.22
 0.13 
 1.05 
 0.13 
14NVS Novartis AG ADR
0.22
 0.07 
 1.03 
 0.07 
15RDY Dr Reddys Laboratories
0.21
(0.04)
 1.19 
(0.05)
16AZN AstraZeneca PLC ADR
0.17
(0.01)
 1.17 
(0.01)
17PBH Prestige Brand Holdings
0.13
(0.03)
 1.24 
(0.04)
18ORMP Oramed Pharmaceuticals
0.13
(0.02)
 2.89 
(0.05)
19JAZZ Jazz Pharmaceuticals PLC
0.11
 0.05 
 1.55 
 0.08 
20RPRX Royalty Pharma Plc
0.11
 0.05 
 1.29 
 0.07 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.